Neural mechanisms of tolerance to the effects of cocaine

Ronald P. Hammer, Yaprak Egilmez, Michael W. Emmett-Oglesby

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Chronic use of cocaine in high doses can produce tolerance as assessed by various behavioral, neurochemical, cellular and molecular measures in specific brain regions. Tolerance to cocaine is indicated by drug discrimination and intracranial self-stimulation models, which show the development of tolerance after approximately 1 week of frequent cocaine treatment, with recovery after a similar period of cocaine abstinence. Tolerance to the reinforcing properties of cocaine depends on dose, duration and frequency of cocaine self-administered by experimental animal or human subjects. The mechanism underlying this effect may involve an absolute or relative attenuation of dopamine response to cocaine challenge after frequent or repeated treatment in the nucleus accumbens (NAc). Similarly, afferent and efferent NAc circuits exhibit reduced metabolic activity, which lasts throughout the early period of withdrawal following repeated treatment. Attenuation of immediate early gene response also occurs, which might be related to a functional desensitization of dopamine D1-like receptors. Furthermore, intracellular adaptive responses to chronic cocaine exposure induce striatal dynorphin expression decreasing the behavioral potency of subsequent drug treatment. Thus, a combination of various pharmacodynamic mechanisms and the attenuation of dopamine response induced by sufficient dose, duration and frequency of cocaine exposure ultimately invoke the transient development of tolerance to the reinforcing effects of cocaine.

Original languageEnglish (US)
Pages (from-to)225-239
Number of pages15
JournalBehavioural Brain Research
Volume84
Issue number1-2
DOIs
StatePublished - Mar 1997

Fingerprint

Cocaine
Nucleus Accumbens
Dopamine
Self Stimulation
Corpus Striatum
Dynorphins
Dopamine D1 Receptors
Immediate-Early Genes
Therapeutics
Pharmaceutical Preparations
Brain

Keywords

  • adaptation
  • chronic
  • cocaine
  • deoxygluco se
  • drug discrimination
  • dynorphin
  • immediate early gene
  • reinforcement
  • self-administration
  • tolerance

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Neural mechanisms of tolerance to the effects of cocaine. / Hammer, Ronald P.; Egilmez, Yaprak; Emmett-Oglesby, Michael W.

In: Behavioural Brain Research, Vol. 84, No. 1-2, 03.1997, p. 225-239.

Research output: Contribution to journalArticle

Hammer, Ronald P. ; Egilmez, Yaprak ; Emmett-Oglesby, Michael W. / Neural mechanisms of tolerance to the effects of cocaine. In: Behavioural Brain Research. 1997 ; Vol. 84, No. 1-2. pp. 225-239.
@article{a62d29eb6de943e4a0148fd74100e7f3,
title = "Neural mechanisms of tolerance to the effects of cocaine",
abstract = "Chronic use of cocaine in high doses can produce tolerance as assessed by various behavioral, neurochemical, cellular and molecular measures in specific brain regions. Tolerance to cocaine is indicated by drug discrimination and intracranial self-stimulation models, which show the development of tolerance after approximately 1 week of frequent cocaine treatment, with recovery after a similar period of cocaine abstinence. Tolerance to the reinforcing properties of cocaine depends on dose, duration and frequency of cocaine self-administered by experimental animal or human subjects. The mechanism underlying this effect may involve an absolute or relative attenuation of dopamine response to cocaine challenge after frequent or repeated treatment in the nucleus accumbens (NAc). Similarly, afferent and efferent NAc circuits exhibit reduced metabolic activity, which lasts throughout the early period of withdrawal following repeated treatment. Attenuation of immediate early gene response also occurs, which might be related to a functional desensitization of dopamine D1-like receptors. Furthermore, intracellular adaptive responses to chronic cocaine exposure induce striatal dynorphin expression decreasing the behavioral potency of subsequent drug treatment. Thus, a combination of various pharmacodynamic mechanisms and the attenuation of dopamine response induced by sufficient dose, duration and frequency of cocaine exposure ultimately invoke the transient development of tolerance to the reinforcing effects of cocaine.",
keywords = "adaptation, chronic, cocaine, deoxygluco se, drug discrimination, dynorphin, immediate early gene, reinforcement, self-administration, tolerance",
author = "Hammer, {Ronald P.} and Yaprak Egilmez and Emmett-Oglesby, {Michael W.}",
year = "1997",
month = "3",
doi = "10.1016/S0166-4328(97)83332-3",
language = "English (US)",
volume = "84",
pages = "225--239",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Neural mechanisms of tolerance to the effects of cocaine

AU - Hammer, Ronald P.

AU - Egilmez, Yaprak

AU - Emmett-Oglesby, Michael W.

PY - 1997/3

Y1 - 1997/3

N2 - Chronic use of cocaine in high doses can produce tolerance as assessed by various behavioral, neurochemical, cellular and molecular measures in specific brain regions. Tolerance to cocaine is indicated by drug discrimination and intracranial self-stimulation models, which show the development of tolerance after approximately 1 week of frequent cocaine treatment, with recovery after a similar period of cocaine abstinence. Tolerance to the reinforcing properties of cocaine depends on dose, duration and frequency of cocaine self-administered by experimental animal or human subjects. The mechanism underlying this effect may involve an absolute or relative attenuation of dopamine response to cocaine challenge after frequent or repeated treatment in the nucleus accumbens (NAc). Similarly, afferent and efferent NAc circuits exhibit reduced metabolic activity, which lasts throughout the early period of withdrawal following repeated treatment. Attenuation of immediate early gene response also occurs, which might be related to a functional desensitization of dopamine D1-like receptors. Furthermore, intracellular adaptive responses to chronic cocaine exposure induce striatal dynorphin expression decreasing the behavioral potency of subsequent drug treatment. Thus, a combination of various pharmacodynamic mechanisms and the attenuation of dopamine response induced by sufficient dose, duration and frequency of cocaine exposure ultimately invoke the transient development of tolerance to the reinforcing effects of cocaine.

AB - Chronic use of cocaine in high doses can produce tolerance as assessed by various behavioral, neurochemical, cellular and molecular measures in specific brain regions. Tolerance to cocaine is indicated by drug discrimination and intracranial self-stimulation models, which show the development of tolerance after approximately 1 week of frequent cocaine treatment, with recovery after a similar period of cocaine abstinence. Tolerance to the reinforcing properties of cocaine depends on dose, duration and frequency of cocaine self-administered by experimental animal or human subjects. The mechanism underlying this effect may involve an absolute or relative attenuation of dopamine response to cocaine challenge after frequent or repeated treatment in the nucleus accumbens (NAc). Similarly, afferent and efferent NAc circuits exhibit reduced metabolic activity, which lasts throughout the early period of withdrawal following repeated treatment. Attenuation of immediate early gene response also occurs, which might be related to a functional desensitization of dopamine D1-like receptors. Furthermore, intracellular adaptive responses to chronic cocaine exposure induce striatal dynorphin expression decreasing the behavioral potency of subsequent drug treatment. Thus, a combination of various pharmacodynamic mechanisms and the attenuation of dopamine response induced by sufficient dose, duration and frequency of cocaine exposure ultimately invoke the transient development of tolerance to the reinforcing effects of cocaine.

KW - adaptation

KW - chronic

KW - cocaine

KW - deoxygluco se

KW - drug discrimination

KW - dynorphin

KW - immediate early gene

KW - reinforcement

KW - self-administration

KW - tolerance

UR - http://www.scopus.com/inward/record.url?scp=0343923442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343923442&partnerID=8YFLogxK

U2 - 10.1016/S0166-4328(97)83332-3

DO - 10.1016/S0166-4328(97)83332-3

M3 - Article

C2 - 9079787

AN - SCOPUS:0343923442

VL - 84

SP - 225

EP - 239

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 1-2

ER -